Research Report on Global Genomic Market is a professional and comprehensive report on the Genomic industry. The report monitors the key trends and market drivers in the current scenario and offers on-the-ground insights.
The global “genomics market” size is projected to reach USD 62614.6 million by 2026. Genomics has successfully transformed the way of preventing, managing and treating diseases. Researchers at the University of Paris-Saclay believe that we have entered into the third revolution of sequencing technology in the world of genetics. Moreover, several companies are planning to build third-generation sequencing technology to stay abreast of new trends. As per a recent report published by Fortune Business Insights, titled “Genomics Market Size, Share and Industry Analysis By Type (Products, Services), Technology (Polymerase Chain Reaction, Next-generation Sequencing, Microarray, Sanger Sequencing), Application (Diagnostics, Research), End-User (Research Institutes, Healthcare Facilities and Diagnostic Centers, Pharmaceutical and Biotechnological Companies, Contract Research Organization (CROs)) and Regional Forecast, 2019 2026,” the market value stood at USD 15888.8 million in 2018 and is anticipated to exhibit an exponential CAGR of 18.7% during the forecast period.
Report Highlights:
Request a Sample Copy of the Research Report:https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/genomics-market-100941
Key Companies and Manufacturers Covered:
The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight.
Start-ups to Focus on Providing Genomics Services to Customers
Veritas Genomics announced the launch of new genome sequencing products in November 2018. The company aims to enhance its customer service and expand its product portfolio. Other companies such as Agilent Technologies, Inc., Illumina, Inc., and F. Hoffmann-La Roche Ltd are expected to lead the market in the forecast period. This is mainly on account of their strong product portfolio and wide geographical reach. Among these companies, Illumina acquired a leading position in 2018 owing to the acquisition of Pacific Biosciences.
Advancements in Bioinformatics to Boost the Market in North America
Among regions, North America is anticipated to emerge dominant in the global genomics market throughout the forecast years. In 2018, the market value stood at USD 6959.3 million. This is ascribable to the rising focus on pharmacogenomics and technological advancements in bioinformatics. This, coupled with increasing adoption of new sequencing technologies, will create growth opportunities for the market in this region. Rising preference for personalized medicines is another factor responsible for the dominance of market in this region.
Apart from North America, the market in Europe is expected to exhibit a higher CAGR owing to the robust support from governments, especially in the U.K. Asia Pacific is expected to hold a considerable genomics market share over the projected horizon. Factors such as increasing the aging population, high demand for genetic sequencing in China, and expansion of healthcare system are positively impacting the genomics market growth in this region.
For more information in the analysis of this report, visit:https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941
Detailed Table of Content:
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2.Executive Summary
3.Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4Market Trends
4.Key Insights
4.1GenomicsResearch Spending – For Key Countries, 2018
4.2RegulatoryScenario – For Key Countries
4.3Overview of Genomics Service Provider
4.4New Product Launch
4.5Start-upswith their Funding Overview
4.5Key Industry Developments – Mergers, Acquisitions and Partnerships
5.Global Genomics Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast By Type
5.2.1Product
5.2.1.1Instrumentsand Software
5.2.1.2Consumables
5.2.2Services
5.3. Market Analysis, Insights and Forecast By Technology
5.3.1PolymeraseChain Reaction (PCR)
5.3.2Next-generationSequencing (NGS)
5.3.3Microarray
5.3.4SangerSequencing
5.3.5Others
5.4. Market Analysis, Insights and Forecast By Application
5.4.1Diagnostics
5.4.2Research
5.4.3Others
5.5. Market Analysis, Insights and Forecast By End User
5.5.1ResearchInstitutes
5.5.2HealthcareFacilities and Diagnostic Centers
5.5.3Pharmaceuticaland Biotechnological Companies
5.5.4ContractResearch Organization (CROs)
5.6. Market Analysis, Insights and Forecast By Region
5.6.1NorthAmerica
5.6.2Europe
5.6.3AsiaPacific
5.6.4LatinAmerica
5.6.5MiddleEast and Africa
6.North America Genomics Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis By Type
6.2.1Product
6.2.1.1Instrumentsand Software
6.2.1.2Consumables
6.2.2Services
6.3. Market Analysis By Technology
6.3.1PolymeraseChain Reaction (PCR)
6.3.2Next-generationSequencing (NGS)
6.3.3Microarray
6.3.4SangerSequencing
6.3.5Others
6.4. Market Analysis By Application
6.4.1Diagnostics
6.4.2Research
6.4.3Others
6.4. Market Analysis By End User
6.5.1ResearchInstitutes
6.5.2HealthcareFacilities and Diagnostic Centers
6.5.3Pharmaceuticaland Biotechnological Companies
6.5.4ContractResearch Organization (CROs)
6.6. Market Analysis By Country
6.6.1U.S.
6.6.2Canada
Continued…
Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/genomics-market-100941
Research Methodology:
Fortune Business Insights follows a robust research methodology that involves data triangulation based on top-down, bottom-up approaches, and validation of the estimated market numbers through primary research. The information used to estimate the market size and forecast for various segments at the global, regional, and country level is derived from the most credible published sources and through interviews with the right stakeholders.
Growth rate or CAGR exhibited by a market for a certain forecast period is calculated on the basis of various factors and their level of impact on the market. These factors include market drivers, restraints, industry challenges, market and technological developments, market trends, etc.
Reasons to Purchase this Report:
Order Full Report:https://www.fortunebusinessinsights.com/checkout-page/100941
KEY QUESTIONS ANSWERED:
More Trending Topics From Fortune Business Insights@
Nasal Drug Delivery Devices Market
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email:sales@fortunebusinessinsights.com
Press Release Distributed by The Express Wire
To view the original version on The Express Wire visit Genomics Market Business Opportunities, Impacting Factors, Latest Innovations, Growth and Share Forecast to 2026